Table 1: Patient's demographics
| Age Groups | 50 -< 75 years N = 108 | ≥ 75 years N = 105 | ||
| N = 108 | N = 105 | |||
| Indication | p = 0.899 | |||
| Screening Diagnostic Surveillance |
48 (44.4%) 30 (27.8%) 30 (27.8%) |
44 (41.9%) 32 (30.5%) 29 (27.6%) |
p = 0.708 p = 0.665 p = 0.979 |
|
| High Grade Lesion | 20 (18.5%) | 14 (13.3%) | p = 0.302 | |
| Screening Diagnostic Surveillance |
4/48 (8.3%) 7/30 (23.3%) 9/30 (30%) |
8/44 (18.2%) 5/32 (15.6%) 1/29 (3.4%) |
p = 0.161 p = 0.443 p = 0.007 |
|
| Died | 11 (10.3%) | 26 (24.8%) | p = 0.005 | |
| Survival times (months) | 131.1 ± 3.7 | 106.9 ± 3.5 | p = 0.009 | |
| Screening Diagnostic Surveillance |
138.9 ± 3.5 107.3 ± 6.9 105.4 ± 5.9 |
110.3 ± 5.1 93.9 ± 6.8 116.8 ± 4.8 |
p = 0.019 p = 0.055 p = 0.087 |
Data: Mean ± SE. High grade lesions: adenomas > 1 cm, tubulovillous adenomas, villous polyps, high-grade dysplasia or cancer.